Nucleic Acid Amplification Testing Market: By Technique, By Application, Cancer, Personalized Medicine, and Genetic and Mitochondrial Disorders), and Geography  

Nucleic Acid Amplification Testing Market Size, Share, Growth, Trends, and Global Industry Analysis: By Technique (Target amplification systems, Probe amplification systems, and Signal amplification), By Application (Infectious Diseases (Viruses, Bacteria, and Others), Cancer, Personalized Medicine, and Genetic and Mitochondrial Disorders), and Region  

Nucleic Acid Amplification Testing Market size was valued at US$ 1,951.4 million in 2023 and is poised to grow at a CAGR of 9.4% from 2024 to 2030. One advantage of signal amplification systems is that they provide more options for target recognition sequences in some circumstances. The increased prevalence of infectious diseases, the rising need for better diagnostic measures, and rising investment in developing new biotechnological diagnostic procedures are driving the nucleic acid amplification testing market. Furthermore, nucleic acid amplification testing delivers the most exact detection. It is thus frequently preferred over older methods, owing to the growing need for improved testing methods and the biopharmaceutical industry's increased R&D expenditure.  However, the lack of skilled professionals and high costs hampers the nucleic acid amplification testing market. For COVID-19 (SARS-CoV-2), a Nucleic Acid Amplification Test (NAAT) is a form of a viral diagnostic test. NAATs are genetic material detectors (nucleic acids). SARS-CoV-2 NAATs identify the RNA (ribonucleic acid) sequences that make up the virus's genetic material.

Moreover, rise in R&D for the development of advanced technologies for nucleic acid testing, an increase in demand for early-stage disease diagnosis and personalized medicine, rise in funding from public and private sectors for the healthcare infrastructure development, and surge in demand for nucleic acid testing from blood banks are anticipated to boost the market over the forecast timeframe. However, stringent regulatory guidelines, high cost and complexity in the testing, and lack of skilled professionals and sophisticated healthcare infrastructure in underdeveloped countries are hinder the growth of market in future years.

For instance, according to WHO 2018 data, approximately 9.6 Mn death occurred due to cancer around the globe. Moreover, rise in R&D for the development of advanced technologies for nucleic acid testing, increased in demand for early stage disease diagnosis and personalized medicine, raise in funding from public and private sectors for the healthcare infrastructure development, and surge in demand for nucleic acid testing from blood banks are anticipated to boost the market over the forecast timeframe. However, stringent regulatory guidelines, high cost and complexity in the testing, and lack of skilled professionals and sophisticated healthcare infrastructure in underdeveloped countries are hinder the growth of market in future years.

Nucleic Acid Amplification Testing Market Key Developments:

In January 2021, Xpert Xpress SARS-CoV-2 of Cepheid was launched for the qualitative detection of nucleic acid from the SARS-CoV-2 in upper respiratory specimens.

Nucleic Acid Amplification Testing Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

9.4%

Largest Market

Asia Pacific

Fastest Growing Market

North America

Nucleic Acid Amplification Testing Market Dynamics

Nucleic Acid Amplification Testing market is surging owing to frequent acquisitions and launchings by the market players. Strategic alliances by the players such as acquisitions, mergers, expansions, and new product launches may enhance the company's growth. For instance, In March 2020, Abbott launched Abbott's point-of-care ID NOW platform, a molecular point-of-care test to detect novel coronavirus in as little as five minutes

Nucleic Acid Amplification Testing Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 1,951.4 million

Market CAGR

9.4%

By Technique

  • Target amplification systems
  • Probe amplification systems
  • Signal amplification

By Application

  • Infectious Diseases
  • Cancer
  • Personalized Medicine
  • Genetic and Mitochondrial Disorders

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa (MEA)

Key Features of the Report

  • The nucleic acid amplification testing market report provides granular level information about the market size, regional market share, historic market (2018-2022), and forecast (2023-2029)
  • The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Download Free Sample Report

Frequently Asked Questions

The nucleic acid amplification testing market is projected to expand at a CAGR of 9.4% during the forecast period.

Hoffmann-La Roche, Becton, Dickinson and Company, Beckman Coulter, Abbott Laboratories, Illumina, Siemens Healthineers

North America is dominating the nucleic acid amplification testing market

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Nucleic Acid Amplification Testing Market Introduction 
2.1.Global Nucleic Acid Amplification Testing Market  - Taxonomy
2.2.Global Nucleic Acid Amplification Testing Market  - Definitions
2.2.1. By Technique
2.2.2. By Application
2.2.3. By Region
3.Global Nucleic Acid Amplification Testing Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Nucleic Acid Amplification Testing Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Nucleic Acid Amplification Testing Market  By Technique, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Target amplification systems
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Probe amplification systems
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Signal amplification
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6.Global Nucleic Acid Amplification Testing Market  By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Infectious Diseases
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Cancer
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Personalized Medicine
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Genetic and Mitochondrial Disorders
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7.Global Nucleic Acid Amplification Testing Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Asia Pacific (APAC)
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Middle East and Africa (MEA)
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Latin America
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8.North America Nucleic Acid Amplification Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. Technique Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1.Target amplification systems
8.1.2.Probe amplification systems
8.1.3.Signal amplification
8.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1.Infectious Diseases
8.2.2.Cancer
8.2.3.Personalized Medicine
8.2.4.Genetic and Mitochondrial Disorders
8.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.3.1.United States of America (USA)
8.3.2.Canada
9.Europe Nucleic Acid Amplification Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. Technique Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Target amplification systems
9.1.2.Probe amplification systems
9.1.3.Signal amplification
9.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Infectious Diseases
9.2.2.Cancer
9.2.3.Personalized Medicine
9.2.4.Genetic and Mitochondrial Disorders
9.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Germany
9.3.2.France
9.3.3.Italy
9.3.4.United Kingdom (UK)
9.3.5.Spain
10.Asia Pacific (APAC) Nucleic Acid Amplification Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Technique Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Target amplification systems
10.1.2.Probe amplification systems
10.1.3.Signal amplification
10.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Infectious Diseases
10.2.2.Cancer
10.2.3.Personalized Medicine
10.2.4.Genetic and Mitochondrial Disorders
10.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.China
10.3.2.India
10.3.3.Australia and New Zealand (ANZ)
10.3.4.Japan
10.3.5.Rest of APAC
11.Middle East and Africa (MEA) Nucleic Acid Amplification Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Technique Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Target amplification systems
11.1.2.Probe amplification systems
11.1.3.Signal amplification
11.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Infectious Diseases
11.2.2.Cancer
11.2.3.Personalized Medicine
11.2.4.Genetic and Mitochondrial Disorders
11.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.GCC Countries
11.3.2.South Africa
11.3.3.Rest of MEA
12.Latin America Nucleic Acid Amplification Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Technique Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Target amplification systems
12.1.2.Probe amplification systems
12.1.3.Signal amplification
12.2.  Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Infectious Diseases
12.2.2.Cancer
12.2.3.Personalized Medicine
12.2.4.Genetic and Mitochondrial Disorders
12.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Brazil
12.3.2.Mexico
12.3.3.Rest of LA
13. Competition Landscape
13.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
13.2.1.Hoffmann-La Roche
13.2.2.Becton
13.2.3.Dickinson and Company
13.2.4.Beckman Coulter
13.2.5.Abbott Laboratories
13.2.6.Illumina
13.2.7.Siemens Healthineers
13.2.8.bioMerieux
13.2.9.Novartis
13.2.10.Bio-Rad Laboratories
14. Research Methodology 
15. Appendix and Abbreviations 

Key Market Players

  • Hoffmann-La Roche
  • Becton
  • Dickinson and Company
  • Beckman Coulter
  • Abbott Laboratories
  • Illumina
  • Siemens Healthineers
  • bioMerieux
  • Novartis
  • Bio-Rad Laboratories

Related Industry Reports